IVAX Corporation

The Ivax Corporation is a huge Florida-based health company. Norton Healthcare, the largest generic drugs company in Britain, is a subsidiary of IVAX. Norton's Head Office is located London's Docklands and, according to Chairman and CEO Isaac Kaye, it was positioned there 'owing to the area's proximity to the City of London and to the European Medicines Evaluation Agency'

Isaac Kaye earned $550,301 at IVAX in 1998 (plus share options worth up to $1.5 million) and $521,520 in 1997.. In 2006 IVAX was aquired by Teva which is described as 'Israel's largest company'. The aquisition is reported to have created 'the world's largest generics company'..

Kaye is reported to have stepped down as chairman of Norton Healthcare in 2003. Plunkett's Health Care Industry Almanac reports IVAX profits totalling $243,200,000 for 2001, $131,000,000 for 2000 and $70,700,000 for 1999. Their sales totals were $1,215,400,000, $793,400,000, and $656,500,000 respectively.

In 2001, IVAX is reported to have 'achieved record earnings of $1.2bn'

People

• Isaac Kaye

In 2003, the following people are reported as serving IVAX...

• Frank Condella - Managing Director in the UK
• Dan Weiner - Senior Vice President for Global Clinical Development
• Steve Marcus - Senior Vice President for Proprietary Pharmaceutical Business Development.
• Nick Vodar - Director of Drug Discovery and the Director of IVAx's Institute for Drug Research in Budapest, Hungary.
• Betty Amos - Board member. Amos is the owner and president of The Abkey Companies and a franchisee of Fuddruckers restaurants.
• Mitch Medique - Board member. Medique also serves on the board of several public companies (including National Semiconductor and Carnival Corporations). He is also a past chairman of The Beacon Council (Miami's economic development authority)
• Burt Pitt. Pitt is also a professor of cardiology at the University of Michigan School of Medicine.
• Philip Frost - Board member
• Neil Flanzraich - Board member
• Jane Hsiao - Board member
• Mark Andrews - Board member
• Ernst Biekert- Board member
• Jack Fishman- Board member
• Richard Pfenniger Jr. - Board member
• David Lieberman - Board member

IVAX's Board of Directors in 2002 are reported as including...

• Neil Flanzraich - Vice Chairman and President of IVAX Corporation
• Jane Hsiao - Vice Chairman of Technical Affairs and Chief Technical Officer of IVAX Corporation.
• Mark Andrews - President of Great Spirits Company.
• Ernst Biekert - Professor of Chemistry at the University of Heidelberg.
• Charles M Fernandez - President and Chief Executive Officer of Big City Radio.
• Jack Fishman - Director of Research at Strang Cancer Research Laboratory
• Richard C Pfenniger Jr. - Chief Executive Officer and Director of Whitman Education Group, Inc.

Aquisitions and Partnerships

In 2004, IVAX is reported to have aquired ChemSource Corporation (which is based in Puerto Rico) .

ChemSource is reported to have 'recently entered into a license agreement with Novartis Pharma AG to utilize the patented multi-dose dry powder inhaler, Airmax, for Novartis's trademarked medicines Foradil and Miflonide in the European Union and certain other countries'.

In 2002, it is reported that IVAX 'established a company in France by acquiring Merck Sharp & Dohme's portfolio of generic products there.

Litigation

In July 2003, Business Wire reports that IVAX 'received the first of a series of payments from B Braun Melsungen AG, under a number of agreements, for certain patent and product rights and for settlement of litigation'. No further details were disclosed.

In 2003, Thomas Beier, Senior Vice President and Chief Financial Officer for IVAX reported 'Operating expenses' which included a $6.6 million legal settlement. No further details were disclosed.

Subsidiaries and Brands

The IVAX Corporation's other subsidiaries include Zenith Goldline Pharmaceuticals, Goldcaps Inc., Diamedix Corporation, Baker Norton Pharmaceuticals, Immunovision and DVM Pharmaceuticals (all based in Florida), Gelkaps GmbH (Germany), Elvetium S.A. (Argentina), Baker Norton Asia (Hong Kong), Delta Biologicals (Italy) and Galena a.s. Opava (Czech Republic).

In 2002, IVAX is reported to have 'recently' aquired Puerto Rican based company ChemSource (Which develops, manufactures and sells active pharmaceutical ingredients for a variety of pharmaceuticals products)

In 2002, it is also reported that IVAX 'established a company in France by acquiring Merck Sharp & Dohme's portfolio of generic products there. IVAX also 'entered into a collaboration with Novartis' in order to market IVAX's Airmax multidose dry powder inhaler.

In 2002, Plunkett's Health Care Industry Almanac describes IVAX's 'Brands/Divisions/Affiliates' as...

• Airmax
• Easi-Breathe
• Paxene
• Paxoral
• TP-38
• ChemSource Corporation.
• IVAX Pharmaceuticals Inc.

Brands, Divisions and Affiliates

• Norton Healthcare

In 2004, Plunkett's Health Care Industry Almanac reports the following 'Brands/Divisions/Affiliates' of IVAX...

• Airmax
• Easi-Breathe
• Paxene
• Paxoral
• TP-38
• ChemSource Corporation
• IVAX Pharmaceuticals Inc.
• Novartis Pharma AG

In 2001, IVAX announced that it had acquired 99.9% of the shares of Laboratorio Chile S.A

IVAX acquired Laboratorios Elmor S.A. in 2000 (located in Caracas, Venezuela)

In 1996, IVAX merged with the Bergen Brunswig Corporation(which provided American wide distribution of pharmaceuticals and medical-surgical supplies to chain and independent pharmacies, hospitals, HMOs, nursing homes, clinics and physician groups) to create BBI Healthcare.